173 related articles for article (PubMed ID: 20349107)
1. The selective COX-2 inhibitor Etoricoxib reduces acute inflammatory markers in a model of neurogenic laryngitis but loses its efficacy with prolonged treatment.
Lima-Rodrigues M; Lamas N; Valle-Fernandes A; Cruz A; Vieira A; Oliveira P; Pedrosa J; Castro AG; Reis RM; Baltazar F; Almeida A
Inflamm Res; 2010 Sep; 59(9):743-53. PubMed ID: 20349107
[TBL] [Abstract][Full Text] [Related]
2. A new model of laryngitis: neuropeptide, cyclooxygenase, and cytokine profile.
Lima-Rodrigues M; Valle-Fernandes A; Lamas N; Cruz A; Baltazar F; Milanezi F; Nunes R; Reis RM; Pedrosa J; Castro AG; Almeida A
Laryngoscope; 2008 Jan; 118(1):78-86. PubMed ID: 18251032
[TBL] [Abstract][Full Text] [Related]
3. Effect of etoricoxib, a cyclooxygenase-2 selective inhibitor on aberrant crypt formation and apoptosis in 1,2 dimethyl hydrazine induced colon carcinogenesis in rat model.
Sharma P; Kaur J; Sanyal SN
Nutr Hosp; 2010; 25(1):39-48. PubMed ID: 20204254
[TBL] [Abstract][Full Text] [Related]
4. Angiostatic role of the selective cyclooxygenase-2 inhibitor etoricoxib (MK0663) in experimental lung cancer.
Nadda N; Vaish V; Setia S; Sanyal SN
Biomed Pharmacother; 2012 Sep; 66(6):474-83. PubMed ID: 22681911
[TBL] [Abstract][Full Text] [Related]
5. Cyclooxygenase-2 expression on ifosfamide-induced hemorrhagic cystitis in rats.
Macedo FY; Baltazar F; Almeida PR; Távora F; Ferreira FV; Schmitt FC; Brito GA; Ribeiro RA
J Cancer Res Clin Oncol; 2008 Jan; 134(1):19-27. PubMed ID: 17638016
[TBL] [Abstract][Full Text] [Related]
6. The cyclooxygenase-2 inhibitor etoricoxib is a potent chemopreventive agent of colon carcinogenesis in the rat model.
Saini MK; Sharma P; Kaur J; Sanyal SN
J Environ Pathol Toxicol Oncol; 2009; 28(1):39-46. PubMed ID: 19392653
[TBL] [Abstract][Full Text] [Related]
7. Benefits of the antioxidant and anti-inflammatory activity of etoricoxib in the prevention of ovarian ischemia/reperfusion injury induced experimentally in rats.
Yapca OE; Turan MI; Yilmaz I; Salman S; Gulapoglu M; Suleyman H
J Obstet Gynaecol Res; 2014 Jun; 40(6):1674-9. PubMed ID: 24888933
[TBL] [Abstract][Full Text] [Related]
8. Effect of pre-emptive analgesia on clinical parameters and tissue levels of TNF-α and IL-1β in third molar surgery: a triple-blind, randomized, placebo-controlled study.
Albuquerque AFM; Fonteles CSR; do Val DR; Chaves HV; Bezerra MM; Pereira KMA; de Barros Silva PG; de Lima BB; Soares ECS; Ribeiro TR; Costa FWG
Int J Oral Maxillofac Surg; 2017 Dec; 46(12):1615-1625. PubMed ID: 28610818
[TBL] [Abstract][Full Text] [Related]
9. Antiepileptogenic effects of the selective COX-2 inhibitor etoricoxib, on the development of spontaneous absence seizures in WAG/Rij rats.
Citraro R; Leo A; Marra R; De Sarro G; Russo E
Brain Res Bull; 2015 Apr; 113():1-7. PubMed ID: 25701797
[TBL] [Abstract][Full Text] [Related]
10. Treatment with paracetamol, ketorolac or etoricoxib did not hinder alveolar bone healing: a histometric study in rats.
Fracon RN; Teófilo JM; Moris IC; Lamano T
J Appl Oral Sci; 2010 Dec; 18(6):630-4. PubMed ID: 21308296
[TBL] [Abstract][Full Text] [Related]
11. Effects of selective COX-2 inhibition on allergen-induced bronchoconstriction and airway inflammation in asthma.
Daham K; James A; Balgoma D; Kupczyk M; Billing B; Lindeberg A; Henriksson E; FitzGerald GA; Wheelock CE; Dahlén SE; Dahlén B
J Allergy Clin Immunol; 2014 Aug; 134(2):306-13. PubMed ID: 24461582
[TBL] [Abstract][Full Text] [Related]
12. Pain management after elective hallux valgus surgery: a prospective randomized double-blind study comparing etoricoxib and tramadol.
Brattwall M; Turan I; Jakobsson J
Anesth Analg; 2010 Aug; 111(2):544-9. PubMed ID: 20584877
[TBL] [Abstract][Full Text] [Related]
13. Clinical pharmacology of etoricoxib.
Capone ML; Tacconelli S; Patrignani P
Expert Opin Drug Metab Toxicol; 2005 Aug; 1(2):269-82. PubMed ID: 16922642
[TBL] [Abstract][Full Text] [Related]
14. Classic NSAID and selective cyclooxygenase (COX)-1 and COX-2 inhibitors in healing of chronic gastric ulcers.
Brzozowski T; Konturek PC; Konturek SJ; Sliwowski Z; Pajdo R; Drozdowicz D; Ptak A; Hahn EG
Microsc Res Tech; 2001 Jun; 53(5):343-53. PubMed ID: 11376495
[TBL] [Abstract][Full Text] [Related]
15. Tolerability to etoricoxib in patients with aspirin-exacerbated respiratory disease.
Koschel D; Weber CN; Höffken G
J Investig Allergol Clin Immunol; 2013; 23(4):275-80. PubMed ID: 23964558
[TBL] [Abstract][Full Text] [Related]
16. Anti-proliferative and apoptotic effects of etoricoxib, a selective COX-2 inhibitor, on 1,2-dimethylhydrazine dihydrochloride-induced colon carcinogenesis.
Tanwar L; Piplani H; Sanyal S
Asian Pac J Cancer Prev; 2010; 11(5):1329-33. PubMed ID: 21198287
[TBL] [Abstract][Full Text] [Related]
17. Etoricoxib in the treatment of Korean patients with osteoarthritis in a double-blind, randomized controlled trial.
Yoo MC; Yoo WH; Kang SB; Park YW; Kim SS; Moon KH; Song YW; Min BW; Cho YJ; Moon SH; Bin SI; Baek HJ; Shim SC; Lee SW; Yoo DH; Mehta A; Skuban A; Cukrow DM; Vandormael K; Yan L
Curr Med Res Opin; 2014 Dec; 30(12):2399-408. PubMed ID: 25133963
[TBL] [Abstract][Full Text] [Related]
18. A randomized, controlled, clinical trial of etoricoxib in the treatment of rheumatoid arthritis.
Matsumoto AK; Melian A; Mandel DR; McIlwain HH; Borenstein D; Zhao PL; Lines CR; Gertz BJ; Curtis S;
J Rheumatol; 2002 Aug; 29(8):1623-30. PubMed ID: 12180720
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of intrinsic apoptotic pathway in NSAIDs mediated chemoprevention of experimental lung carcinogenesis.
Setia S; Sanyal SN
Pharmacol Rep; 2012; 64(3):615-24. PubMed ID: 22814015
[TBL] [Abstract][Full Text] [Related]
20. Antiinflammatory effects of etoricoxib alone and combined with NSAIDs in LPS-induced reactive arthritis.
Bressan E; Tonussi CR
Inflamm Res; 2008 Dec; 57(12):586-92. PubMed ID: 19109739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
